[T1 bladder carcinoma: prognostic value of the muscularis mucosae invasion (T1a/T1b). A multicenter study by the French Urological Association (CCAFU)]
- PMID: 20538209
- DOI: 10.1016/j.purol.2010.02.002
[T1 bladder carcinoma: prognostic value of the muscularis mucosae invasion (T1a/T1b). A multicenter study by the French Urological Association (CCAFU)]
Abstract
Objective: The aim of this multicenter study was to determine the prognostic value of the depth of invasion of lamina propria and more specifically the influence of the invasion of the muscularis mucosae on survival parameters in T1 bladder carcinoma.
Patients: Six urological centers included patients between 1994 and 2004 who had an initial T1 bladder tumor. All T1 tumors were substaged according to the muscularis mucosae (MM) invasion into T1a (no invasion beyond the MM) and T1b (invasion beyond MM but preserving the muscle). Among the 387 patients included, 269 (69.5%) were found T1a and 118 (30.5%) T1b. Mean follow-up was 45.4 months. T1a and T1b groups were comparable except for tumor grade that was higher in T1b (p<0.001).
Results: Survival without recurrence was not significantly different between T1a and T1b groups (p<0.3) but T1a stage was found as an independent factor for survival without progression (RR=0.49; IC 95%=[0.71-0.90]), specific survival (RR=0.33; IC 95%=[0.16-0.67]) and global survival (RR=0.52; IC 95%=[0.32-0.85]).
Conclusion: This study, the largest on the subject to our knowledge, have shown that muscularis mucosae invasion was a prognostic factor for survival without progression, specific survival, and global survival. We support that routine pathological assessment of the level of MM invasion in patients with stage T1 bladder cancer should be included in the histopathological report.
Copyright 2010 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.Eur Urol. 2005 Aug;48(2):231-8; discussion 238. doi: 10.1016/j.eururo.2005.04.013. Eur Urol. 2005. PMID: 15963635
-
Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.J Urol. 2013 Jun;189(6):2069-76. doi: 10.1016/j.juro.2012.11.120. Epub 2012 Nov 28. J Urol. 2013. PMID: 23201497
-
Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?Urol Int. 2008;80(4):413-8. doi: 10.1159/000132700. Epub 2008 Jun 27. Urol Int. 2008. PMID: 18587253 Clinical Trial.
-
Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.J Urol. 2004 Jan;171(1):149-52. doi: 10.1097/01.ju.0000099825.98542.a8. J Urol. 2004. PMID: 14665864 Review.
-
Sub-Staging-Specific Differences in Recurrence-Free, Progression-Free, and Cancer-Specific Survival for Patients with T1 Bladder Cancer: A Systematic Review and Meta-Analysis.Urol Int. 2020;104(7-8):580-586. doi: 10.1159/000506238. Epub 2020 Jul 1. Urol Int. 2020. PMID: 32610323
Cited by
-
Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?Bladder Cancer. 2015 Sep 5;2(1):1-14. doi: 10.3233/BLC-150022. Bladder Cancer. 2015. PMID: 27376120 Free PMC article. Review.
-
Prognostic role of substaging in T1G3 transitional cell carcinoma of the urinary bladder.Mol Clin Oncol. 2014 Jul;2(4):575-580. doi: 10.3892/mco.2014.290. Epub 2014 May 8. Mol Clin Oncol. 2014. PMID: 24940498 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical